argenx SE reported $6.44 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 6.14 4.48 Oct/22
FY2026Q2 Jun/2026 6.44 5.41 3.27 Jul/23
FY2026Q1 Mar/2026 4.69 4.7 2.29 May/07
FY2025Q4 Dec/2025 6.80 5.14 11.32 Feb/26
FY2025Q3 Sep/2025 4.48 3.89 1.28 Oct/30




Eps Change Date
AstraZeneca USD 2.63 0.05 Jun/2026
Genmab DKK 3.69 2.77 Dec/2025
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
GRIFOLS EUR 0.23 0.09 Jun/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Qiagen NV USD 0.46 0.06 Mar/2026
UCB EUR 5.65 3.21 Dec/2025